|
|
|
Volumn 25, Issue 5 SUPPL., 1998, Pages 47-52
|
|
Promising new agents for treatment of patients with colorectal cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 (3,4 DICHLOROPHENYL) 3 (2,3 DIHYDROBENZOFURAN 5 YLSULFONYL)UREA;
6 HYDROXYMETHYLACYLFULVENE;
BIZELESIN;
CAPECITABINE;
FOLIC ACID ANTAGONIST;
IRINOTECAN;
NIMESULIDE;
NSC 615291;
ONYX 015;
PEMETREXED;
PROSTAGLANDIN SYNTHASE INHIBITOR;
SULFONYLUREA DERIVATIVE;
THYMIDYLATE SYNTHASE INHIBITOR;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
CLINICAL TRIAL;
COLON POLYP;
COLORECTAL CANCER;
DRUG MECHANISM;
HEMOLYTIC ANEMIA;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MAXIMUM ALLOWABLE CONCENTRATION;
METHEMOGLOBINEMIA;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RECTUM POLYP;
REVIEW;
THROMBOCYTOPENIA;
ADENOVIRIDAE;
ANTINEOPLASTIC AGENTS;
BENZOFURANS;
COLORECTAL NEOPLASMS;
DRUG SCREENING ASSAYS, ANTITUMOR;
ENZYME INHIBITORS;
HUMANS;
INDOLES;
PHENYLUREA COMPOUNDS;
SESQUITERPENES;
THYMIDYLATE SYNTHASE;
TUMOR CELLS, CULTURED;
UREA;
|
|
EID: 0031752963
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (16)
|
|
References (41)
|
